A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
Clinical trial NCT07326709 · RECRUITING
Trial details
- NCT number
- NCT07326709
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-24
- Primary completion
- 2030-04-02
- Enrollment
- 770
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.